title: What's new in prostate cancer screening and prevention?
abstract: Prostate cancer is extremely common but causes death in only a minority of men in whom it develops, facts that raise issues regarding screening and treatment morbidity. Two large trials of screening with prostate-specific antigen (PSA) measurements came to seemingly opposite conclusions. Furthermore, a large trial of selenium and vitamin E found that these agents have no value as preventive agents.
authors: Glickman Urological and Kidney Institute, Q10-1, Cleveland Clinic, Cleveland, OH 44195, USA. kleine@ccf.org
authors: Eric A
authors: EA
authors: Klein
mesh_terms: D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods / Q000706:statistics & numerical data; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000517:prevention & control*
chemical_list: D017430:Prostate-Specific Antigen